Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 103,300 shares, an increase of 225.9% from the February 13th total of 31,700 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 487,700 shares, the short-interest ratio is presently 0.2 days.
Analyst Upgrades and Downgrades
Several research firms recently commented on RBGLY. HSBC raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 11th. Barclays downgraded shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 4th. Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Finally, Royal Bank of Canada reissued an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Investing in Travel Stocks Benefits
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.